{'Perf YTD': '8.34%', 'Index': '-', 'Current Ratio': '13.80', 'Inst Trans': '6.05%', 'Perf Quarter': '-49.12%', 'stockname': 'ATRA', 'Shs Float': '20.33M', 'Volume': '0.87', 'Short Float': '12.30%', 'ATR': 'A Atara Biotherapeutics, Inc.', 'Earnings': 'Nov 16', 'Income': '-40.60M', 'Inst Own': '71.80%', '52W Low': '68.49%', 'SMA20': '1.15%', 'PEG': '-', 'P/C': '5.33', 'Prev Close': '28.98', 'Target Price': '64.50', 'P/E': '-', 'Oper Margin': '-', 'Insider Trans': '-22.91%', 'ROA': '-33.00%', 'Market Cap': '826.22M', 'SMA200': '-27.63%', 'Beta': '-', '52W Range': '17.20 - 65.56', 'Debt/Eq': '0.00', 'Shs Outstand': '28.51M', 'EPS this Y': '64.80%', 'LT Debt/Eq': '0.00', 'Sales Q/Q': '-', 'P/FCF': '-', 'Perf Year': '51.09%', 'Short Ratio': '7.52', 'Employees': '18', 'Change': '0.00%', 'Volatility': '8.80% 10.15%', 'Payout': '-', 'Insider Own': '1.80%', 'Rel Volume': '0.87', 'ROI': '-', 'Perf Week': '21.36%', 'Recom': '1.60', '52W High': '-55.80%', 'EPS (ttm)': '-3.44', 'EPS Q/Q': '-169.60%', 'SMA50': '-19.80%', 'Dividend': '-', 'Perf Month': '-15.21%', 'Cash/sh': '5.44', 'Gross Margin': '-', 'EPS past 5Y': '0.00%', 'Perf Half Y': '-25.84%', 'Quick Ratio': '13.80', 'Sales': '-', 'EPS next Q': '-0.56', 'Profit Margin': '-', 'Optionable': 'Yes', 'EPS next Y': '-3.01', 'Shortable': 'Yes', 'Price': '64.50', 'Avg Volume': '332.28K', 'Sales past 5Y': '-'}